Trial · NCT03036813
Adverse events321
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
101 to 120 of 321
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Pruritus | Skin and subcutaneous tissue disorders | Voxelotor 1500 mg | 4 | 88 | 4 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Placebo | 3 | 91 | 6 |
| serious | Anaemia | Blood and lymphatic system disorders | Voxelotor 900 mg | 3 | 92 | 3 |
| serious | Anaemia | Blood and lymphatic system disorders | Voxelotor 1500 mg | 0 | 88 | 0 |
| serious | Anaemia | Blood and lymphatic system disorders | Placebo | 2 | 91 | 2 |
| serious | Pyrexia | General disorders | Voxelotor 900 mg | 3 | 92 | 4 |
| serious | Pyrexia | General disorders | Voxelotor 1500 mg | 2 | 88 | 2 |
| serious | Pyrexia | General disorders | Placebo | 3 | 91 | 3 |
| serious | Pleural effusion | Respiratory, thoracic and mediastinal disorders | Voxelotor 900 mg | 0 | 92 | 0 |
| serious | Pleural effusion | Respiratory, thoracic and mediastinal disorders | Voxelotor 1500 mg | 2 | 88 | 2 |
| serious | Pleural effusion | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 91 | 0 |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | Voxelotor 900 mg | 0 | 92 | 0 |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | Voxelotor 1500 mg | 2 | 88 | 2 |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 91 | 1 |
| serious | Malaria | Infections and infestations | Voxelotor 900 mg | 3 | 92 | 5 |
| serious | Malaria | Infections and infestations | Voxelotor 1500 mg | 1 | 88 | 1 |
| serious | Malaria | Infections and infestations | Placebo | 0 | 91 | 0 |
| serious | Gastritis | Gastrointestinal disorders | Voxelotor 900 mg | 2 | 92 | 2 |
| serious | Gastritis | Gastrointestinal disorders | Voxelotor 1500 mg | 0 | 88 | 0 |
| serious | Gastritis | Gastrointestinal disorders | Placebo | 0 | 91 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03036813/events?page=6